410 related articles for article (PubMed ID: 33549033)
21. Multicentric development and evaluation of
Lucia F; Bourbonne V; Pleyers C; Dupré PF; Miranda O; Visvikis D; Pradier O; Abgral R; Mervoyer A; Classe JM; Rousseau C; Vos W; Hermesse J; Gennigens C; De Cuypere M; Kridelka F; Schick U; Hatt M; Hustinx R; Lovinfosse P
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2514-2528. PubMed ID: 36892667
[TBL] [Abstract][Full Text] [Related]
22. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.
Takiar V; Fontanilla HP; Eifel PJ; Jhingran A; Kelly P; Iyer RB; Levenback CF; Zhang Y; Dong L; Klopp A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1045-50. PubMed ID: 23332221
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
[TBL] [Abstract][Full Text] [Related]
24. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
[TBL] [Abstract][Full Text] [Related]
25. Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma.
Fastrez M; Goffin F; Vergote I; Vandromme J; Petit P; Leunen K; Degueldre M
Acta Obstet Gynecol Scand; 2013 Aug; 92(8):895-901. PubMed ID: 23590725
[TBL] [Abstract][Full Text] [Related]
26. Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area.
Uzan C; Souadka A; Gouy S; Debaere T; Duclos J; Lumbroso J; Haie-Meder C; Morice P
Oncologist; 2011; 16(7):1021-7. PubMed ID: 21659610
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS
Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings.
Ramirez PT; Jhingran A; Macapinlac HA; Euscher ED; Munsell MF; Coleman RL; Soliman PT; Schmeler KM; Frumovitz M; Ramondetta LM
Cancer; 2011 May; 117(9):1928-34. PubMed ID: 21509770
[TBL] [Abstract][Full Text] [Related]
29. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.
Rose PG; Adler LP; Rodriguez M; Faulhaber PF; Abdul-Karim FW; Miraldi F
J Clin Oncol; 1999 Jan; 17(1):41-5. PubMed ID: 10458216
[TBL] [Abstract][Full Text] [Related]
31. Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?
Leblanc E; Katdare N; Narducci F; Bresson L; Gouy S; Morice P; Ferron G; Querleu D; Martinez A
Int J Gynecol Cancer; 2016 Jan; 26(1):169-75. PubMed ID: 26569062
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
Voglimacci M; Gabiache E; Lusque A; Ferron G; Ducassou A; Querleu D; Motton S; Chantalat E; Courbon F; Martinez A
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1551-1559. PubMed ID: 30729273
[TBL] [Abstract][Full Text] [Related]
33. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.
Frumovitz M; Ramirez PT; Macapinlac HA; Klopp AH; Nick AM; Ramondetta LM; Jhingran A
Int J Gynecol Cancer; 2012 Sep; 22(7):1203-7. PubMed ID: 22810967
[TBL] [Abstract][Full Text] [Related]
34. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
[TBL] [Abstract][Full Text] [Related]
35. Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: A single institutional experience.
Mezquita G; Muruzabal JC; Perez B; Aguirre S; Villafranca E; Jurado M
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():79-83. PubMed ID: 30889424
[TBL] [Abstract][Full Text] [Related]
36. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
37. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
Morkel M; Ellmann A; Warwick J; Simonds H
Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Yilmaz B; Dağ S; Ergul N; Çermik TF
Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
[TBL] [Abstract][Full Text] [Related]
40. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Tong SY; Lee JM; Ki KD; Choi YJ; Seol HJ; Lee SK; Huh CY; Kim GY; Lim SJ
Int J Gynecol Cancer; 2012 May; 22(4):654-8. PubMed ID: 22398711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
